{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:49:13Z","timestamp":1782949753551,"version":"3.54.5"},"reference-count":15,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Pharm. Bull.","CHEMICAL &amp; PHARMACEUTICAL BULLETIN"],"published-print":{"date-parts":[[2024,3,30]]},"DOI":"10.1248\/cpb.c24-00032","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T22:18:26Z","timestamp":1711750706000},"page":"345-348","source":"Crossref","is-referenced-by-count":7,"title":["Eperisone Hydrochloride, a Muscle Relaxant, Is a Potent P2X7 Receptor Antagonist"],"prefix":"10.1248","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4275-5723","authenticated-orcid":false,"given":"Makoto","family":"Okada","sequence":"first","affiliation":[{"name":"ASKA Pharmaceutical Co., Ltd., Research Management Department"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nose","sequence":"additional","affiliation":[{"name":"ASKA Pharmaceutical Co., Ltd., Drug Development Department"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Harding M. W., Galat A., Uehlimg D. E., Shreiber S. L., <i>Nature<\/i> (London), <b>341<\/b>, 758\u2013760 (1989).","DOI":"10.1038\/341758a0"},{"key":"2","unstructured":"2) Cabitza P., Randelli P., <i>Eur. Rev. Med. Pharmacol. Sci.<\/i>, <b>12<\/b>, 229\u2013235 (2008)."},{"key":"3","unstructured":"3) Beltrame A., Grangi\u00e8 S., Guerra L., <i>Minerva Med.<\/i>, <b>99<\/b>, 347\u2013352 (2008)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tsuda M., Tozaki-Saitoh H., Inoue K., <i>Curr. Opin. Pharmacol.<\/i>, <b>12<\/b>, 74\u201379 (2012).","DOI":"10.1016\/j.coph.2011.10.014"},{"key":"5","unstructured":"5) Smith J. A., Kitt M. M., Morice A. H., <i>et al.<\/i>, <i>Lancet Respir. Med.<\/i>, <b>8<\/b>, 775\u2013785 (2020)."},{"key":"6","unstructured":"6) <i>Drug Interview Form<\/i>, Myonal tablets 50\u2009mg Myonal Granules 10% (Eperisone Hydrochloride formulation), a muscle relaxant, revised December 2015."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Surprenant A., Rassendren F., Kawashima E., North R. A., Buell G., <i>Science<\/i>, <b>272<\/b>, 735\u2013738 (1996).","DOI":"10.1126\/science.272.5262.735"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Inoue K., Koizumi S., Tsuda M., Shigemoto-Mogami Y., <i>Life Sci.<\/i>, <b>74<\/b>, 189\u2013197 (2003).","DOI":"10.1016\/j.lfs.2003.09.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Dell\u2019Antonio G., Quattrini A., Cin E. D., Fulgenzi A., Ferrero M. E., <i>Neurosci. Lett.<\/i>, <b>327<\/b>, 87\u201390 (2002).","DOI":"10.1016\/S0304-3940(02)00385-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Chessell I. P., Hatcher J. P., Bountra C., Michel A. D., Hughes J. P., Green P., Egerton J., Murfin M., Richardson J., Peck W. L., Grahames C. B. A., Casula M. A., Yiangou Y., Birch R., Anand P., Buell G. N., <i>Pain<\/i>, <b>114<\/b>, 386\u2013396 (2005).","DOI":"10.1016\/j.pain.2005.01.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Honore P., Donnelly-Roberts D., Namovic M. T., Hsieh G., Zhu C. Z., Mikusa J. P., Hernandez G., Zhong C., Gauvin D. M., Chandran P., Harris R., Medrano A. P., Carroll W., Marsh K., Sullivan J. P., Faltynek C. R., Jarvis M. F., <i>J. Pharmacol. Exp. Ther.<\/i>, <b>319<\/b>, 1376\u20131385 (2006).","DOI":"10.1124\/jpet.106.111559"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) King B. F., <i>Br. J. Pharmacol.<\/i>, <b>151<\/b>, 565\u2013567 (2007).","DOI":"10.1038\/sj.bjp.0707266"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Risti\u0107 D., Ellrich J., <i>Cephalalgia<\/i>, <b>32<\/b>, 544\u2013553 (2012).","DOI":"10.1177\/0333102412444013"},{"key":"14","unstructured":"14) <i>Drug Interview Form<\/i>, Antispasmodic Muscalm Tab. 50\u2009mg Muscalm Tab. 100\u2009mg Muscalm Gra. 100\u2009mg\/g Tolperisone Hydrochloride preparation, revised June 2012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Novales-Li P., Sun X. P., Takeuchi H., <i>Eur. J. Pharmacol.<\/i>, <b>168<\/b>, 299\u2013305 (1989).","DOI":"10.1016\/0014-2999(89)90791-7"}],"container-title":["Chemical and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpb\/72\/3\/72_c24-00032\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T03:31:04Z","timestamp":1734147064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpb\/72\/3\/72_c24-00032\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/cpb.c24-00032","relation":{},"ISSN":["0009-2363","1347-5223"],"issn-type":[{"value":"0009-2363","type":"print"},{"value":"1347-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]},"article-number":"c24-00032"}}